Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...

There have been a slew of studies recently supporting the notion that the same mechanisms that help folks lose weight ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new study ...

Today is World Diabetes Day, and Mississippi is leading the nation with the highest number of diabetic patients.  With so ...